EagleBio/iLite C5a分析就绪细胞/BM4075

价格
面议
货号:BM4075
浏览量:127
品牌:EagleBio
服务
全国联保
正品保证
正规发票
签订合同
商品描述

iLite C5a Assay Ready Cells

iLite iLite C5a Assay Ready Cells are Developed and Manufactured by Svar Life Science

The Eagle Biosciences iLite C5a Assay Ready Cells are intended for:

    • Quantification of C5a activity
    • Determination of inhibitory activity against either C5a itself or against the C5a receptor in test samples

Content: >250 µL of Assay Ready Cells suspended in cryoprotective medium from Gibco
Receipt and Storage: Upon receipt confirm that adequate dry-ice is present, and the cells are frozen. Immediately transfer to -80°C storage. Cells should be stored at -80°C (do not store at any other temperature) and are stable as supplied until the expiry date shown. Cells should be used within 30 min of thawing and should be diluted immediately after thawing.
For Research Use Only


Key benefits of iLite® Assays

  • Highly specific reporter gene cell lines
  • Very sensitive cell line responses (>10 fold inductions)
  • Assay Ready Cells – ready-to-use from the freezer, without culturing of cells
  • Assays within a workday (typically 4-7 hour assays)
  • Normalization gene, which eliminates unwanted matrix effects

Product Description

iLite® C5a Assay Ready Cells are human HEK293[1] cells (ATCC# CRL-1573) which have been genetically engineered and optimized to be responsive to human complement component 5a (C5a), resulting in a proportional expression of Firefly Luciferase. Normalization of cell counts, and serum matrix effects is obtained by a second reporter gene, a Renilla Luciferase reporter gene construct, under control of a constitutive promotor.

[1] The HEK-293 cell line has been used under a license obtained from AdVec Inc.


Products Related to iLite C5a Assay Ready Cells

Complement C4d ELISA Assay Kit
Terminal Complement Complex (TCC) ELISA Assay Kit

EagleBio的iLite®分析就绪细胞iLite®  技术基于报告基因检测格式,经过修改和适用于整个药物开发周期中的应用以及生物药物的监测。这些细胞系可以开发用于任何生物制药靶标,并且可以使用相同的细胞系轻松设置药物效力(即药物活性)的测定方法。检验就绪的细胞经过基因工程处理,可与报告基因检验技术一起使用,以检测药物效力和NAb。